Clementia Pharmaceuticals Inc. is a listed company. Filings by its managers are published through SEDI. No insider at Clementia Pharmaceuticals Inc. has published a filing in the past twelve months. The most recent one dates from 24 April 2019.
Our records for Clementia Pharmaceuticals Inc. go back to 2017, with no purchases and 10 sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 29 declarations
Clementia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for rare diseases and musculoskeletal disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.